Skip to main content
. Author manuscript; available in PMC: 2017 Nov 28.
Published in final edited form as: AIDS. 2016 Nov 28;30(18):2855–2864. doi: 10.1097/QAD.0000000000001250

Table 1.

Baseline characteristics among adult (age ≥ 15 years) residents of SEARCH intervention communities who linked to care after baseline CHC and before follow-up year 1 CHC (N = 5683)

Uganda-West (N = 1306) Uganda-East (N = 674) Kenya (N = 3703) Total (N = 5683)
Sex
 Male [n (%)] 219 (32.5%) 219 (32.5%) 1163 (31.4%) 1863 (32.8%)
 Female [n (%)] 455 (67.5%) 455 (67.5%) 2540 (68.6%) 3820 (67.2%)
Age [years, median (IQR)] 36 (29–44) 39 (31–46) 37 (29–46)
 15–19 years 42 (3.2%) 20 (3.0%) 75 (2.0%) 137 (2.4%)
 20–24 years 130 (10.0%) 43 (6.4%) 293 (7.9%) 466 (8.2%)
 25–29 years 189 (14.5%) 83 (12.3%) 619 (16.7%) 891 (15.7%)
 30–34 years 232 (17.8%) 91 (13.5%) 604 (16.3%) 927 (16.3%)
 35–39 years 207 (15.9%) 118 (17.5%) 617 (16.7%) 942 (16.6%)
 40–44 years 187 (14.3%) 125 (18.6%) 447 (12.1%) 759 (13.4%)
 > 45 years 319 (24.4%) 194 (28.8%) 1048 (28.3%) 1561 (27.5%)
Education
 No School 230 (17.6%) 123 (18.3%) 184 (5%) 537 (9.5%)
 Primary or less 794 (60.8%) 405 (60.1%) 3214 (86.8%) 4413 (77.7%)
 Any Secondary or further 282 (21.6%) 144 (21.4%) 293 (7.9%) 313 (5.5%)
 Don’t know/refused to answer 0 1 (0.2%) 12 (0.3%) 13 (0.2%)
Occupation
 Farming 858 (65.7%) 485 (72.0%) 2118 (57.2%) 3461 (65.7%)
 Fishing 1 (0.1%) 3 (0.5%) 417 (11.3%) 421 (7.4%)
 Shopkeeper/Vendor 103 (7.9%) 30 (4.5%) 425 (11.5%) 558 (9.8%)
 Household worker 50 (3.8%) 30 (4.5%) 175 (4.7%) 255 (4.5%)
 Transport worker 26 (2.0%) 13 (1.9%) 33 (0.9%) 72 (1.3%)
 Student 18 (1.4%) 12 (1.8%) 42 (1.1%) 72 (1.3%)
 Other 194 (14.9%) 78 (11.6%) 299 (8.1%) 571 (10.1%)
 No Job 56 (4.3%) 23 (3.4%) 194 (5.2%) 273 (4.8%)
Mobility status
 Stable n(%) 1258 (96.3%) 658 (97.6%) 3628 (98%) 5544 (97.5%)
 Mobile n(%) 48 (3.7%) 16 (2.4%) 75 (2.0%) 139 (2.5%)
Access to mobile phone [n (%)] 758 (58.0%) 306 (45.4%) 2657 (71.8%) 3721 (65.5%)
CD4 at baseline CHC
 <50 cells/mm3 10 (0.8%) 8 (1.2%) 24 (0.7%) 42 (0.7%)
 50–200 cells/mm3 93 (7.1%) 59 (8.8%) 188 (5.1%) 340 (6.0%)
 200–350 cells/mm3 231 (17.7%) 127 (18.8%) 543 (14.4%) 892 (15.7%)
 350–500 cells/mm3 326 (25.0%) 166 (24.6%) 783 (21.1%) 1275 (22.4%)
 >500 cells/mm3 588 (45.0%) 281 (41.7%) 1827 (49.3%) 2696 (47.4%)
 Missing baseline CD4 58 (4.4%) 33 (4.9%) 347 (9.4%) 438 (7.7%)
Pre-ART CD4 above country treatment guidelines§ 408 (31.2%) 196 (29.1%) 653 (17.6%) 1257 (22.1%)
HIV RNA < 500 copies/ml 431 (33.0%) 190 (28.2%) 1656 (44.7%) 2277 (40.1%)
 Missing baseline viral load 381 (29.2%) 193 (28.6%) 873 (23.6%) 1245 (21.9%)
Previous linkage to care [n (%)] 743 (56.9%) 396 (58.8%) 2943 (79.5%) 4082 (71.8%)
On ART before baseline CHC [n (%)] 585 (44.8%) 318 (47.2%) 2359 (63.7%) 3262 (57.4%)
HIV Testing Location
 CHC* 1075 (82.3%) 606 (89.9%) 2701 (72.9%) 4382 (77.1%)
 HBT** 228 (17.5%) 60 (8.9%) 998 (26.7%) 1286 (22.6%)
 Missing 3 (0.2%) 8 (1.2%) 4 (0.1%) 15 (0.3%)
*

CHC = Community Health Campaign

**

HBT = Home Based Testing

§

Country guidelines for treatment were to initiate ART at CD4 < 350 cells/ml until December 2013 in Uganda and until June 2014 in Kenya, after which country treatment guidelines were changed to reflect the 2013 WHO guidelines of ART initiation at CD4 < 500 cells/ml